[How to cook Ding Guiyu]_How to make_How to make

[How to cook Ding Guiyu]_How to make_How to make

Many people don’t know much about tunny fish. This is a fish species with relatively high nutritional value. It has a good role in promoting the absorption of nutrients in the human body. It is used to supplement the body’s calcium, protein, and nutrition.Can play a certain role, the practice of Ding Guiyu is relatively simple, can be used for steaming, can also be used for braising, are more common methods, let’s take a look below.

How to cook Ding Guiyu, steamed Ding Guiyu Ingredients: 1 Ding Guiyu, ginger, spring onion, cooking wine, soy sauce, oil consumption, sesame oil Steps: 1. The fish breaks its belly to go to the gills,Wash your stomach, stomach and lungs, and put a few strokes on your body. 2. Then add cooking wine and soy sauce oil to the fish, and place the shredded ginger and scallion in the sliced fish meat and place them in a plate.Marinate for 30 minutes. 4. Steam over the fire on the steamer for 25 minutes to bring it out. Pour in sesame oil, oyster sauce, and sprinkle with spring onion.

Second, vinegar-burned butchery mandarin fish main ingredients: butchery fish auxiliary ingredients: sea cucumber, cooked ham, winter bamboo shoots, eggs, parsley seasoning: balsamic vinegar, cooking wine, salt, chicken essence, white pepper powder, water starch, spring onion, cooking oil1. Remove the bones, spines, and cut the meat into strips. Add salt, starch, and egg whites to the sizing and taste. Put the fish heads and fish bones in the steamer and cook them. Use the soup for the rest. 2. Cut the bamboo shoots, sea cucumbers, and ham into shreds, pour them into boiling water, remove the drained water, wash the onions, and coriander, and cut them into pieces. 3. Pour the oil on the pan and ignite the oil.Dispense the drained and drained oil into the pan, add the fish soup to the pot, and add sea cucumber, winter bamboo shoots, ham, fish sticks, cooking wine, chicken essence, white pepper, starch, salt, and onion.At the end, add coriander, just add the balsamic vinegar.

[Can oranges and apples be eaten together]_Efficacy_How to eat

銆愭瀛愬拰鑻规灉鑳戒竴璧峰悆鍚椼€慱鍔熸晥_鎬庝箞鍚?
姗樺瓙鍜岃嫻鏋滈兘鏄父瑙佺殑姘存灉锛屼袱鑰呯殑钀ュ吇浠峰€奸兘鏄潪甯搁珮鐨勶紝灏ゅ叾鏄嫻鏋滐紝缁忓父鍚冭嫻鏋滃浜鸿韩浣撳仴搴锋槸鏈夐潪甯稿ぇ鐨勫ソ澶勶紝寰堝浜烘媴蹇冩瀛愬拰鑻规灉涓嶈兘涓€璧峰悆锛岄鐗╀箣闂存槸鐩哥敓鐩稿厠鐨勶紝濡傛灉涓€璧烽鐢ㄤ細瀵硅韩浣撳仴搴锋湁鍗卞锛屾瀛愯櫧鐒跺父瑙侊紝浣嗘槸鏈€濂戒笉瑕佸鍚冿紝鍚冨浜嗘槸浼氬紩璧蜂笂鐏殑銆?妗斿瓙鍜岃嫻鏋滆兘涓€璧峰悆鍚?姗樺瓙鍜岃嫻鏋滄槸鍙互涓€璧峰悆鐨勶紝杩欎袱绉嶉鐗╃殑钀ュ吇骞朵笉鍐茬獊锛岃€屼笖涓€鍚岄鐢ㄥ鍋ュ悍涔熻兘甯︽潵寰堝鐨勫ソ澶勩€備笉杩囬渶瑕佹敞鎰忕殑鏄紝姗樺瓙鍜岃嫻鏋滃湪楗鏂归潰閮芥What’s the difference? It’s a good idea. It’s a very beautiful thing. It’s a very interesting thing. It’s a bit of a sorrow.€鍚岄鐢紝鐢变簬鑻规灉涓惈鏈夎緝澶氱殑闉i吀锛屼竴鍚岄鐢ㄤ細瀵艰嚧铔嬬櫧璐ㄥ彂鐢熸矇娣€锛岃繖涓嶄粎浼氬鑷磋泲鐧借川鐨勪环鍊奸檷浣庯紝鑰屼笖杩樺鏄撳紩璧疯偁鑳冧笉閫傘€傛瀛愬拰鑻规灉鍙互涓€璧峰悆锛岃€屼笖钀ュ吇閮藉彲浠ヨ浜轰綋鍚告敹鍒╃敤锛屼竴璧峰悆鍏锋湁澧炲己椋熸銆佹鼎鑲犻€氫究銆侀€氱粡娲荤粶銆佺敓娲ユ娓淬€侀檷琛€鑴傘€佸仴鑴惧吇鑳冦€佷績杩涙秷鍖栥€佹鼎鑲烘鍜炽€佷繚鎶ゅ績琛€绠°€佸埄灏挎秷鑲裤€佹彁绁炪€佽В閰掋€佽ˉ涓泭姘斻€佽ˉ鑴戙€佽ˉ姘斿吇琛€銆佸畨绁炪€佹敼鑹儏缁€佹竻娲佺墮榻跨瓑鍔熸晥锛岄€傚綋椋熺敤杩樺彲浠ユ不鐤楀彛骞茶垖鐕ャ€佽偤鐐庛€佹秷鍖栦笉鑹€佸姩鑴夌‖鍖栥€侀娆蹭笉鎸€侀珮琛€鑴傘€佹皵琛€涓嶈冻銆佸皬渚夸笉鐣呫€佷究绉樸€佹敮姘旂鐐庛€佸挸鍡姐€佸憰閫嗐€侀ギ閰掕繃搴︺€佹按鑲裤€佺缁忚“寮便€佸け鐪犮€佽传琛€銆佹儏缁笉鍔犮€佸彛鑷瓑涓嶉€傜梾鐥囥€?The world’s most famous people are in the realm of the world. It’s a good thing. It’s a hot pot. It’s very nice. It’s so good. It’s a real thing. It’s a chain.渶瑕佹敞鎰忕殑鍦版柟銆傜┖鑵逛笉瀹滃悆姗樺瓙锛屾瀛愪細瀵硅儍浜х敓杈冨ぇ鐨勫埡婵€锛屼粠鑰屼細瀵硅儍榛忚啘閫犳垚鎹熶激锛屽鏄撹鍙戣儍鐥呫€傝儍閰歌繃澶氭垨鑰呰儍娉涢吀鐨勬偅鑰呬笉鍙悆姗樺瓙锛屾 焛 慪 腑 钖  湁 澶 ч 噺 咯 启 言 賀 х 噿 囿  纴 浼 叔 Twisting inches 鎾 鎯 呮 崮 政 唷 啱 愛 柉 愛х 囿 Lu  纴 亴 尲 尶 尺 夺 椋 啺 敺 啤 駽 惽 撁 鍒 鬎 璎 璎 玧 尧 叧 叴 唴 叴 咴 叐 咐 吐 吠 揠 阿阿 自己 自己 Add the key to the wind and the wind and the wind and the wind and the wind簬閰告€х墿璐ㄧ殑褰卞搷锛屼細褰卞搷鐗欓娇鍋ュ悍銆?鑻规灉椤荤煡鍚冭嫻鏋滃悓鏍锋湁涓嶅皯闇€瑕佹敞鎰忕殑鍦版柟銆傚悆鑻规灉鐨勬椂鍊欎笉瀹滈鐢ㄨ嫻鏋滄牳锛屽叾涓惈鏈夊井閲忕殑姘板寲鐗╋紝铏界劧鍚冭嫻鏋滄牳涔嬪悗瀵逛汉浣撳奖鍝嶄笉澶э紝浣嗘槸缁堢┒浼氬鍋ュ悍閫犳垚涓嶅埄褰卞搷锛屾墍浠ヤ笉鍚冧负濂姐€傛偅鏈夎偁鑳冪値銆佽偁鑳冩簝鐤$瓑鐤剧梾鐨勬偅鑰呬笉瀹There are a lot of rules and regulations, and you have a lot of troubles, and you can’t help them, but you can’t do anything.What is it?

[Eat garlic to lower blood sugar?

】 _Lowering blood sugar_Effect

[Eat garlic to lower blood sugar?
】 _Lowering blood sugar_Effect

More and more people have hyperglycemia. Once they have an understanding of hyperglycemia, they can usually find a way to lower their blood sugar. There are many methods, such as eating some foods that lower blood sugar. There are many such foods.Many of these vegetables and fruits, including yam, onion, and taro, are good products for lowering blood sugar. In addition, eating garlic is also helpful for lowering blood sugar.

Does garlic reduce blood sugar?
1. Garlic can lower blood sugar and prevent diabetes.

Garlic can promote the secretion of insulin, increase the absorption of glucose by tissue cells, increase the body’s glucose tolerance, rapidly reduce blood glucose levels in the body, and eliminate various pathogens that cause diabetes due to infection, thereby effectively preventing and treating diabetes.

2, garlic has good anti-cancer effect.

Elements such as germanium and selenium in garlic can inhibit the growth of tumor cells and nanoparticles. Experiments have found that the population with the lowest incidence of cancer is the population with the highest selenium content in the blood.

The National Cancer Organization believes that garlic is the top plant in the world’s most anti-cancer potential.

In fact, garlic not only has some effects on lowering blood sugar.

It is also very helpful for sterilization and anti-virus.

So usually there is nothing to do with garlic.

There is also a need for diabetic patients to remember that sometimes crushing garlic together will work best.

Because this can better release allicin.

It has a better effect on some diseases.

What other health effects does garlic have?

1. Strong sterilization.

Sulfur-containing compounds in garlic have a surprisingly strong antibacterial and anti-inflammatory effect, and they can inhibit and kill a variety of cocci, bacilli, fungi, and viruses. It is the strongest antibacterial effect found in natural plants.

2. Detoxifying and clearing intestines to prevent gastrointestinal diseases.

Garlic can effectively inhibit and kill bacterial viruses such as Helicobacter pylori that cause gastrointestinal diseases, remove gastrointestinal toxic substances, stimulate the implantation of mucous membranes, promote appetite, and accelerate digestion.

The method of consuming garlic in wine is completely different from garlic marinated in soy sauce, garlic marinated in soy sauce, and vinegar and garlic. It is not to eat garlic in wine, but to drink a small amount of garlic juice.

Speaking of the most commonly used garlic medicinal method in the family, it is garlic wine.

Usually 1 ml of garlic wine contains 8000 micrograms of allicin.

That being said, everyone may not quite understand.

For example, drinking 100 ml of garlic wine has exactly the same effect as eating 5 grams of garlic raw.

Moreover, the stomach wall absorbs allicin together with alcohol, and the effect of drinking garlic wine is better than eating garlic raw.

Of course, it is not recommended for people with gastric ulcers, hyperacidity, and weak stomach function to drink a lot of garlic wine for the first time.

Generally, people who have regular stomach pains after eating, those who have stomachaches on an empty stomach, those who have stomachaches at night, people who often have sore stomachs, people who can’t accumulate food, people who often feel sick, and have broken stomachPeople, you should start with 5 ml of garlic wine and increase it a little bit.

[How to cook cooked duck]_How to make_Making method

銆愮啛楦瓙鎬庝箞鍋氬ソ鍚冦€慱濡備綍鍋歘鍒朵綔鏂规硶
楦瓙鑲変篃鏄瘮杈冨父瑙佺殑鑲夌被锛岄腑瀛愯倝鍏锋湁寰堝ソ鐨勫幓鐏殑浣滅敤锛屾瘮杈冮€傚悎鍦ㄥ澶╁悆锛岄腑瀛愯倝濡傛灉娌℃湁鍚冨畬锛岃繖鏃跺€欏彲浠ュ仛涓€浜涘叾浠栫殑椋熸潗锛屼篃闈炲父鐨勭編鍛筹紝姣斿璇村彲浠ュ仛鎴愯懕鐑ч腑锛屽彲浠ョ敤楦倝鏉ョ倰鑿滐紝鎴栬€呮槸鐢ㄨ幉钘曟潵鍋氶腑鑲夛紝閮芥槸姣旇緝濂界殑鏂规硶锛岃兘澶熷惛鏀堕腑鐨勯鍛冲効锛岃繕鑳藉鍘婚櫎缇婅倝鐨勬补鑵汇€傜啛楦瓙鎬庝箞鍋氬ソ鍚冧富鏂欓腑鑲?300g鑾茶棔 300g鏂规硶/姝ラ楦倝娲楀噣鍒囧ぇ鍧椼€傝幉钘曞幓鐨悗鍒囨垚鍘氱墖銆傞攨涓€掑叆灏戣娌瑰€掑叆楦倝銆傚緟楦倝鍐呯殑娌硅剛鐓庡嚭鍚庢斁鍏ヨ挏绫冲拰濮滅墖銆傚姞鍏ヤ竴鍕虹洂鍜屼竴鍕鸿眴鐡i叡銆傛妸鍒囧ソ鐨勮幉钘曠墖鍊掑叆閿呬腑銆傚€掑叆閫傞噺鏂欓厭銆傚姞鍗婂嫼绯栵紝鐢熸娊锛岃€佹娊锛岄€傞噺姘达紝鐩栦笂閿呯洊鐐栫叜10鍒嗛挓銆傝懕鐑ч腑銆傜敤涓€鏂ゅ缁嗙殑钁憋紙鍗楁柟绉颁綔绫宠懕锛屼竴灏哄乏鍙抽暱锛屾瘮绛峰瓙鐣ョ粏涓€鐐癸級娲楀噣鍒囦簩瀵告潵闀跨殑灏忔銆傚鐢ㄣ€備竴鍙腑娲楀噣銆佸垏鍧楋紝寮€姘撮噷鐒竴涓嬶紝婊ゆ按澶囩敤銆傚紑娌归攨锛岀倰钁憋紝钁辩槳浜嗕互鍚庯紝灏嗛腑鍧楁斁鍦ㄨ懕涓婏紝鍔犵敓濮溿€佸暏閰掋€侀叡娌广€佸皯璁哥洂銆佺硸锛屽ぇ鐏儳寮€鍚庯紝鐢ㄥ皬鐏剸鑷抽腑鐔燂紝鍐嶇敤澶х伀鐑ц嚦姹ゆ祿鍗冲彲璋冨懗涓婄泦銆傛娉曞仛鐨勯腑瀛What are you going to do? Do you want to go through the chain? Do you want to do it? Do you want to go through the chain?鑺嬭壙鐑ч腑銆傝妺鑹垮幓鐨€佹礂鍑€銆佸垏鍧椼€佺叜涓崐鐔熴€傚鐢ㄣ€備竴鍙腑娲楀噣銆佸垏鍧椼€佸紑姘撮噷鐒竴涓嬨€傚鐢ㄣ€傚紑娌归攨锛堝皯璁告补锛夌倰楦潡锛屼緷娆″姞濮滆懕銆佹枡閰掋€佸皯璁哥洂銆侀叡娌癸紝鐑у紑浜嗕互鍚庡姞姘达紝澶х伀鐑у紑鏀瑰皬鐏剸鑷抽腑鍗婄啛鏃讹紝鍔犲叆鑺嬭壙锛屽啀鍔犻€傞噺绯栵紝鐢ㄥぇ鐏儳寮€锛岀敤灏忕伀鐒栫啛锛屾渶鍚庡ぇ鐏敹姹わ紝璋冨懗锛岃捣閿呫€傝妺鑹夸笉鍏堢叜涓€涓嬶紝鎬曠鍒板捀鐨勪細鐓緱鍍佃€屼笉鐑傘€傛娉曞仛鐨勯腑瀛愶紝椴滆€岀朝锛屾槸姹熸禉娌竴甯︾殑涓浼犵粺鑿溿€傚綋鐒堕腑瀛愯繕鍙互鐓叉堡锛屽姞澶╃洰绗嬨€佺帀鍏扮墖銆侀粦鏈ㄨ€炽€佹灨鏉炲瓙绛夎惀鍏讳笉閿欙紝鍐嶅姞鍑犵墖鐏吙锛屽懗閬撴洿浣炽€傞腑瀛愮儳鐓箣鍓嶏紝涓€瀹氳鍦ㄥ紑姘撮噷鐒竴涓嬶紝鍘绘帀涓€浜涢獨鍛炽€?

[Efficacy and role of celery seed powder]_Benefit_Set

銆愯姽鑿滅苯绮夌殑鍔熸晥涓庝綔鐢ㄣ€慱濂藉_鐩婂
The use of silicon is a must-have lawsuit, and the lawsuits have been filed, as well as the lawsuits, and the application of this method is very difficult to find out how to deal with it.湁鎯冲埌杩囧畠杩樻湁淇濆仴鐨勪綔鐢ㄣ€傝姽鑿滅苯绮夊彲浠ョ洿鎺ユ嬁鏉ョ粰浜烘湇鐢紝瀹冨浜庨檷鍘嬨€侀檷琛€鑴傛柟闈㈢殑浣滅敤杩樹笉閿欙紝鍚屾椂涔熷彲浠ュ.楠ㄣ€佸欢缂撹“鑰併€備絾鏄敱浜庤姽鑿滄湰韬殑鎬ц川瀵掑噳锛屾墍浠ヤ笉閫傚疁杩囧鏈嶇敤锛屾湰韬劸鑳冭櫄寮辩殑浜轰篃涓嶈鏈嶇敤銆傜涓€闀挎湡鍚冭姽鑿滅苯鑳介闃查珮琛€鍘嬨€傝姽鑿滃瓙鏈変竴瀹氱殑闄嶅帇鏁堟灉锛屼絾涓嶆槸娌荤枟楂樿鍘嬶紝濡傛灉灞炰簬杞诲害鐨勫彲浠ラ€傚綋鏈嶇敤銆傛敞鎰忎笉瑕佽喘涔板惈鏈夎タ鑽垚鍒嗙殑鑳跺泭鎴栬€呮槸鍏朵粬鍒跺墏锛屾渶濂借嚜宸卞姞宸ャ€傝姽鑿滅苯鍙互娉℃按鍠濊兘闄嶈鍘嬶紝鑺硅彍绫芥湁鍙互杈呭姪闄嶈鍘嬬殑浣滅敤锛屽彲浠ュ皯閲忔湇鐢ㄩ珮琛€鍘嬬梾瑕佺瀛︽不鐤楋紝鍧氭寔鑽墿鎺у埗琛€鍘嬶紝淇濇寔琛€鍘嬬ǔ瀹氾紝棰勯槻骞跺彂鐥囧彂鐢熴€傜浜岄暱鏈熷悆鑺硅彍绫借兘澹銆傝姽鑿滅苯涓惈鏈夊绉嶄汉浣撳繀椤荤殑寰噺鍏冪礌锛屽叾涓挋涓庣7鐨勫惈閲忛兘鐗瑰埆楂橈紝杩欎簺鐗╄川鍙互淇冭繘楠ㄩ鍙戣偛锛屼篃鑳介闃插皬鍎胯蒋楠ㄧ梾鍜屼腑鑰佸勾楂樺彂鐨勯璐ㄧ枏鏉撅紝鍙﹀寰噺鍏冪礌纾疯繕鑳戒繚鎶よ绠★紝涔熻兘闀囬潤瀹夌銆傜涓夐暱鏈熷悆鑺硅彍绫借兘寤剁紦琛拌€併€傝姽鑿滅苯涓惈鏈夊ぉ鐒剁殑娌归唶鍜岃姽鑿滅礌浠ュ強浜氭补閰歌繕鏈夐粍閰被鐗╄川鍜屽井閲忓厓绱犵锛岃繖浜涚墿璐ㄨ浜轰綋鍚告敹浠ュ悗鍙互淇冭繘韬綋鍐呰嚜鐢卞熀鐨勫垎瑙d篃鑳藉噺灏戝畠浠鎵嬬被韬綋鐨勪激瀹筹紝鍙互寤剁紦琛拌€侊紝I ‘m not sure if I ‘m going to do it, I ‘m going to do it, I ‘m going to use it, I ‘m going to go through it, I ‘m going to use it, I ‘m going to use it, I ‘m going to use it, I ‘m going to use itIt ‘s so hard to make sure that it ‘s the best way to get rid of it. It ‘s a raccoon. It ‘s a raccoon.借埄灏背包秷镶匡纴涔熻兘棰勯槻鍏宠妭镣庡拰罐规按浠ュ強鑲剧値绛夊绉嶅父瑙佺梾鐨勫彂鐢熴€傜浜旈暱鏈熷悆鑺硅彍绫界殑鍓綔鐢ㄣ€傝姽鑿滅苯鎬ц川娓╁拰娌℃湁浠€涔堟槑鏄剧殑鍓綔鐢紝鍙互闀挎湡椋熺敤銆備絾鏄偅浜涙偅鏈変範鎯€т究绉樺拰鑴捐儍铏氬瘨鐨勪汉缇や笉鑳介暱鏈熷悆鑺硅彍绫斤紝涓嶇劧浼氬韬綋涓嶅埄锛屽彟澶栦綆琛€鍘嬩汉缇や篃涓嶈兘鍚冭姽鑿滅苯锛屼笉鐒朵細璁╀汉浠洜琛€鍘嬭繃浣庡紩澶Chrysanthemum

Huaxia Happiness (600340): Optimized sales structure, improved cash flow, improved performance, and solid growth

Huaxia Happiness (600340): Optimized sales structure, improved cash flow, improved performance, and solid growth

Huaxia Happiness released three quarterly reports for 2019: From January to September 2019, the company achieved operating income of 643.

2 ten percent, an increase of 42 per year.

48%, net profit attributable to mother was 97.

5 ppm, an increase of 23 in ten years.

71%; basic profit income realized 3.

18 yuan / share, increase 25 later.

2%.

  Opinion cost control achieved results, with steady growth in performance.

On January 9, 2019, the company realized annual revenue growth of 42.

48%, net profit attributable to mothers is increasing by 23.
.

71%; The eye-catching revenue growth was mainly due to the improvement in the scale of the company’s development business; the slower growth rate of 四川耍耍网 performance than the revenue growth rate was mainly due to the tax increase and tax increase, resulting in 112% tax and additional growth.

09%, significantly exceeding the growth rate of revenue.

The company’s expense management is very effective. The sales rate and management expense rate in the first three quarters were 1 respectively.

8%, 6.

9%, at least 1 integer and 5 integers respectively.

The company’s consolidated gross profit margin for the first three quarters of the company reached 40.

4%, with a net interest rate of 15.

2%, profitability remains high.

The company’s advance funds reached 1350.

2 ppm, 1 of 10 years of revenue.

6 times, effectively guarantee the growth of future business performance.

The proportion of sales outside Beijing continued to increase, and the performance of off-site replication was eye-catching.

As of September 20武汉桑拿19, the company achieved such 1006.

45 ‰, a decrease of 6 per year.

56%; the sales area is 9.11 million square meters, which decreases by 5 every year.

29%; from the perspective of regional layout, the company’s sales contribution to projects outside Beijing has gradually increased.

In the first three quarters, the sales ratio of foreign projects in Beijing reached 62%. In the earlier 18 years, 8 crossovers were promoted and 16 were increased step by step.

7%, becoming another major new off-site replication growth point after Nanjing and Hangzhou.

The cooperation was safe and the cash was seized. The cash flow improved significantly.

1) The company’s recovery rate has improved significantly. The company’s cash flow from sales of goods and labor services in the first three quarters reached 645.

69 trillion, accounting for 62 of the sales amount over the same period.

7%, up 13. from the end of 18 years
.

Five single, the increase in sales recovery rate effectively improved the company’s cash flow situation; cash inflows from financing activities reached 938.

9.6 billion, an increase of 65 in ten years.

6%.

2) Cooperate with Ping An to adopt the asset-light model of asset management to effectively revitalize existing assets and optimize the structure of assets and liabilities.
The military company cooperated with Ping An Life of China in real estate projects. The company transferred the subject claims to Ping An Life with a total amount of 58.

At the same time, Ping An entrusted the company to build the target property on the project site, and gradually provided the target property with operation management services. Issuing transactions are of great significance for the company to revitalize the existing assets, optimize the company’s asset and liability structure, and find new growth points.
As of the end of the March 2019 quarter, the company’s asset-liability ratio was 84.

9%, excluding the asset-liability ratio after receipt of 54.

6%, leverage level is controllable.

Investment suggestion: Huaxia Happiness has gradually transitioned from “building a garden with a house” to the stage of “promoting a house with a garden”, moving towards a nationwide layout, and the future industry development service income will grow at a considerable rate.

Ping An’s strategic investment has effectively strengthened the company’s capital strength, and in-depth cooperation in potential business is worth looking forward to.

We expect the company EPS to be 4 in 2019-2021.

84, 6.

00, 7.

20 yuan, corresponding to 5 for PE.

79, 4.

67, 3.

89 times, maintain “Buy” rating.

Risk warning: industry sales fluctuations; policy adjustments leading to operational risks; changes in financing environment; corporate operating risks; exchange rate fluctuation risks; shed reform monetization is not up to expectations.

Kang Hong Pharmaceutical (002773): Expansion of indications for Compaq Medical Insurance in 2020 is imminent

Kang Hong Pharmaceutical (002773): Expansion of indications for Compaq Medical Insurance in 2020 is imminent

Kanghong Pharmaceutical announced the 2019 performance forecast on January 14th: Realizing net profit attributable to mothers6.

9.5 billion to 7.

640,000 yuan, an increase of 0-10% in ten years.

Deduct non-attributed net profit 6.

3 billion to 6.

890,000 yuan, an increase of 0-10% in ten years.

  In the fourth quarter, the company achieved net profit attributable to its mother.

43 ppm to 2.

USD 1.2 billion, a year-on-year increase of -24% to 13%, net of non-attributed net profit1.

26 ppm to 1.

86 ppm, a ten-year increase of -29% to 5%.

  The company’s performance growth in the fourth quarter of 2019 has improved, slightly exceeding expectations.

Compaq’s price has been renewed by 25%. It has renewed its medical insurance negotiating catalog and increased its 杭州桑拿网 indications. The increase in the distribution of potential disease groups covered by medical insurance will promote the growth of Compaq’s sales. The growth of its performance will accelerate and accelerate in 2020, maintaining the company’s “highly recommended” level.

  The performance growth in the fourth quarter of 2019 has improved, and the company’s expense ratio may increase.

  Compaq’s core product is expected to achieve 30% revenue growth in 2019, and Chinese medicine and chemical medicine revenue will grow steadily.

The improvement in the fourth quarter results may be due to higher expense ratios.

We believe that the company’s Chinese medicine and chemical medicine business is expected to continue to grow steadily in 2020.

Compaq’s market space is large, and its products have reached the world’s advanced level. 天津夜网 The penetration rate is currently not more than 2%. It is expected to achieve sustained and rapid growth, and the expense rate is expected to shift to the scale effect of the sales volume of Compaq’s.

  Compaq has reduced the price by 25% and renewed the medical insurance negotiation catalogue, and gradually realized “price for quantity” through new indications.

  Compaq Renewal renews the medical insurance negotiation catalogue with a price reduction of 4,160 yuan / branch, which is 25% lower than the earlier price of 5,550 yuan / branch. The scope of medical insurance coverage has increased “visual impairment caused by diabetic macular edema (DME)” and “choroidal neoplasia”The visual indication of blood vessel (CNV) -induced damage is two indications. The potential patient population covered by medical insurance has grown, and it is expected to achieve a “price-for-amount exchange” and a rapid increase in penetration.

  Compaq’s annual drug use is numerous, and charity assistance projects have further strengthened product market competition. It is expected that next year’s revenue will increase by 30%.

  The ratio of the number of branches of Compaq’s medications is similar to that of similar products ranibizumab and aflibercept. Under the condition that the medical insurance limits the total reimbursement to no more than 9 and no more than 5 in the first year, patients can be more fullyTreatment.

Compaq Ship has implemented the new medical insurance reimbursement policy in January this year. At the same time, it announced that it has also launched a charitable assistance program. For eligible medical insurance patients, buy three needles and one needle for each eye, and buy two needles for on-demand assistance (Within one year), for non-medical patients, buy three needles of on-demand assistance per eye (within one year).

If patients benefit from AIDS assistance, Compaq’s intervention has the lowest price among similar products, and it has also become the only product that can not exceed the 9 branches of Medicare reimbursement under sufficient treatment, which strengthens CompaqXipu’s market competitiveness.

We expect that the number of Compaq drugs used is expected to increase by about 70%, thereby achieving a 30% increase in price reduction and maintaining a rapid growth trend.

  Compaq Overseas Phase III trials are progressing steadily, which is expected to open up the overseas tens of billions of dollars market and achieve long-term sustainable growth.

  The company’s overseas clinical phase III trial of wet age-related macular degeneration is progressing smoothly, and 1,140 patients have been enrolled. Phase III clinical trials of other indications are in progress at the same time, and it will open a US $ 10 billion market after overseas listing.

Compaq’s domestic market promotion and overseas market expansion are expected to achieve long-term sustained growth.

  Earnings forecast: We expect the company to achieve revenues of 32 in 2019-2021.

46 billion, 36.

9.4 billion, 42.

7.6 billion, an increase of 11%, 14%, 16% each year, and net profit attributable to mothers is 7.

3.8 billion, 9.

50 billion, 11.

6.5 billion, an increase of 6%, 29%, 23% each year, and the EPS for 2019-2021 will be 0.

85 yuan, 1.

09 yuan, 1.

33 yuan.The company currently expects a corresponding 20-year PE valuation of 35 times and maintains the company’s “strongly recommended” investment rating.

  Risk reminder: the intensity of medical insurance control costs exceeds expectations; the scale of competition continues to exceed expectations; product development progress is less than expected

Yongyi shares (603600) company express report: Q3 net profit continues high growth Q4 performance improvement can be expected

Yongyi shares (603600) company express report: 杭州夜网论坛 Q3 net profit continues high growth Q4 performance improvement can be expected

Investment Highlights Event: The company released the first three quarters of 2019 performance report, and the company achieved revenue 17 in the first three quarters of 2019.

72 ppm, a ten-year increase4.

45%; net profit attributable to mother 1.

43 ppm, an increase of 93 in ten years.

84%.

Among them, Q3 single quarter revenue 6.

30 ppm, a six-year increase of 6.

31%; net profit attributable to mother 0.

52 ppm, an increase of 98 in ten years.

13%.

  Q3 single-quarter revenue growth increased month-on-month, and net profit continued to grow rapidly.

In the third quarter of 2019, single-quarter revenue and net profit attributable to mothers increased by 6 each year.

31%, 98.

13%, which is proportional to Q2. The company’s 杭州夜网 revenue growth rate improved month-on-month, achieving positive growth, and the growth rate of net profit declined slightly, but remained 98% overall.

13% high growth.

From the perspective of profitability, the company’s gross profit margin in the single quarter of 2019Q3 was 19.

87%, an increase of 3 per year.

46 averages; net margin is 8.
.

39%, an increase of 3 per year.

In 88 aspects, the profitability has improved significantly. We believe that this is mainly due to the continuous optimization of the company’s product structure, the company’s measures to reduce costs and increase efficiency, and the continuous decline in prices of steel and TDI raw materials.

  During Q3, the expense ratio decreased and cost control was good.

Q3 single quarter company period expenses 8.

68%, a year down 3.

31 units, of which the sales expense ratio decreased by 0.

94 averages to 3.

55%, the management expense rate fell by 0.

58 up to 3.

86%, R & D expense ratio decreased by 1.

74 up to 2.

95%, the financial expense ratio decreased by 0.

05 averages to -1.

68%, of which the rate of research and development expenses fell significantly, mainly because the company’s research and development expenses fell in the same period last year, announced a number of patented technologies and launched a number of new products, new technology and new product reserves have been abundant.

  The improvement in Q4 performance can be expected, and the profit side continues to benefit from the decline in raw material prices.

Looking forward to the fourth quarter, we think the company’s continuous improvement in performance can still be expected.

Revenue: 1) The easing of Sino-US trade disputes and the continuous depreciation of the Renminbi will help the continuous improvement of sales revenue to the United States; 2) The company’s Vietnam production base initially achieved normal production and sales, and large-scale production base construction continued to advance at the same time,The orderly expansion of production capacity guarantees the growth of the company’s performance; 3) The company continues to expand the marketing strategy of KAM major customers. The overseas market continues to explore new markets and new customers based on maintaining existing major customers such as IKEA and staples. DomesticThe market deeply cultivates Dadong Aosheng, and focuses on developing distributors offline. It continues to cooperate with multi-network platforms such as Tmall and JD.com to continue to increase sales revenue. 4) On the product side, the company has a large amount of R & D expenses in the early stage and new product reserves.Rich, transforming new products into existing major customers or adding new customers to the procurement system is expected to contribute to revenue.

In terms of profit, the company’s main raw material TDI price continued to fall. At the end, the current mainstream TDI price was 12,800 yuan / ton, which was an earlier decline of 16.

88%, the decline in the price of raw materials is conducive to the continuous improvement of the company’s profit side.
  Investment suggestion: We believe that through the easing of Sino-US trade disputes and the company’s own production capacity, channels, and continuous promotion of products, the company’s revenue growth rate is expected to rebound; the profit side continues to benefit from the decline in raw material prices, and the company reduces costs and increases efficiencyEtc., or continue to maintain high growth.
We adjust the democratic profit forecast and expect the company’s net profit for 2019-2021 to be 1.

85, 2.

36 and 2.

97 ‰, corresponding to 19 times, 15 times, and 12 times the corresponding PE, maintaining the “overweight-A” recommendation.

  Risk reminders: risks brought by international trade frictions; lower than expected risks at production bases in Vietnam; increased competition in the industry; risk of rising prices of major raw materials;

CV Source (002841): Three major businesses in the smart interactive industry drive high growth

CV Source (002841): Three major businesses in the smart interactive industry drive high growth
This report reads: The three major businesses of the global LCD display card, interactive smart tablet market leader, component business (TV board), education business (Sivo tablet), and enterprise business (MAXHUB) drive high growth. Investment Highlights: Raise target price to 92.7 yuan, increase the level.The company is the global market leader in liquid crystal display cards and interactive smart flat panels. In 18 years, it achieved revenue of 17 billion yuan, an increase of 56%; net profit attributable to mothers was 10 billion yuan, an increase of 45%.Based on intelligent interaction, the company’s business has expanded from component business (TV board) to education business (Sivo tablet) and enterprise business (MAXHUB). The three major businesses drive high growth.Based on the 18-year performance bulletin, we raised the EPS for 18 to 1.53 yuan (+ 4%), and at the same time raised 19 and 20 years earnings per share forecast to 2.06 yuan (+ 5%), 2.78 yuan (+ 3%), according to industry estimates, raise the target price to 92.7 yuan. The penetration rate of LCD TV cards continued to increase, and the component business continued to grow rapidly.The company is the world’s leading LCD control 杭州桑拿 panel leader, with the world’s largest market share, and the market share in 2H18 exceeds 40%.With the popularization of smart TVs, the company ‘s smart card expansion ratio has continued to increase, and smart card ASPs have significantly surpassed traditional TV cards, which will drive the company ‘s TV card revenue to continue to grow rapidly.As the prices of upstream components drop, the company’s gross profit margin will gradually rise. Intelligent interactive tablet leader, broad prospects for education business.AVC data shows that 18Q3 companies accounted for 43 of the sales volume and value of interactive tablets.6%, 39.2%, ranking first in the industry, and its sales share increased by 8 percentage points compared with 2017.The company’s education business is committed to extending from classroom application scenarios to 杭州桑拿网 complete educational information application scenarios in schools and school districts. Layout of MAXHUB conference tablet business, nuggets enterprise-level service market.The conference tablet is another blue ocean market. In 18 years, the Chinese conference industry grew at a rate of 68%. The company merged its accumulation in the field of intelligent interaction and launched the MAXHUB conference tablet to replace the industry leader. Risk warning: industry competition is intensifying.

Aerospace Electronics (600879) Third Quarterly Report Review: Inventory and order growth highlight future performance and is expected to improve to create a competitive advantage

Aerospace Electronics (600879) Third Quarterly Report Review: Inventory and order growth highlight future performance and is expected to improve to create a competitive advantage
Event: On October 29, the company released the third quarter results announcement, and achieved operating income of 92 in the first three quarters.$ 8.1 billion, an annual increase of 2.20%; net profit attributable to mother 3.51 ppm, a 10-year increase2.42%; basic income is 0.129 yuan, an annual increase of 2.38%. The first three quarters of performance were maximized and stable, and operating cash flow improved.The company’s operating income in the first three quarters of 2019 has increased annually2.20%, of which the third quarter quarter increased by 3.83%; gross profit margin increased by 0 every year.82, the expense ratio increased during the period, of which R & D expenses exceeded the largest increase to 36.47%, R & D investment continues to increase.As a result of the report, the company’s operating cash flow situation has improved, and its operating net cash flow has achieved further growth.22%, of which sales of cash rebates increased by 10 per year.47%. Production activity has further increased, and inventory and order growth indicate future performance.The maximum increase in advance payments and payable budget year is more than 30%, the company’s production and procurement activities are active; the advance funds also exceeded the increase of 42.7%, indicating that the company has additional orders on hand and inventory growth exceeds 31.93%, which will be gradually recognized as income. Moreover, the annual increase in the budget payable in this period, the 四川耍耍网 inventory and the advance receipts of invoices all exceeded the same period of last year. We believe this may be due to the increase in the company’s production capacity and the continuous increase in orders received.In contrast, the annual increase of the company’s budget receivable was only 4.61%, followed by a consolidation of more than 10 in the same period last year, indicating that the company’s repayment situation has improved. Funding for active development expenditure continued to increase, and fundraising and investment projects continued to advance.The reported large amount of raised cash was mainly used to repay US $ 3 billion of long-term debt repaid. At the same time, on September 3, the company completed the issuance of four ultra short-term financing bonds totaling US $ 3 billion and obtained cash inflows from the raised funds.Development expenditure in this period increased by 53 per year.69%, mainly due to Hangzhou Aerospace Electronic Technology, Beijing Aerospace Times Optoelectronic Technology Project increased.The three major investment projects in 2017, intelligent defense equipment systems, measurement and control communications and aerospace electronic components, and high-end intelligent inertial navigation products related projects were terminated. The cumulative expenditure during the reporting period accounted for 32 of the planned scale.26%, 73.65%, 88.28%. After the project is completed, it will further enhance the company’s competitive advantage in the market. Leading companies in aerospace electronic products, drones and precision guided bombs create new competition.The company has deeply cultivated the field of aerospace electronics technology. Aerospace measurement and control communications, electromechanical components, integrated circuits, and inertial navigation are traditional advantages of the company. It has always maintained a domestic leading level in the industry and the market has basically shown a steady upward trend.In addition, the company has obvious competitive advantages in the field of drones and precision guided bombs, and has developed rapidly.The subsidiary Aerospace Feihong has formed system-level products represented by drones, and its core technologies and products have market-oriented competitiveness. The “Fei Teng” series of precision guided bombs is the only overall unit of Aerospace Science and Technology Group.Well-known, these businesses will help the company to create profit growth points on multiple product lines in the future. The 9th Academy of Aerospace is the only listed platform, which is expected to benefit from the restructuring of the group’s institutes in the future.The Ninth Academy of Aerospace is a subsidiary of China Aerospace Science and Technology Corporation. It is a large-scale scientific research and production consortium of aerospace electronics. The company is the only listing platform affiliated to the 9th Academy of Aerospace.The reorganization injected a 100% stake in Aerospace Electric, a subsidiary of the Ninth Academy, and Time Optoelectronics 58.With 73% equity and other internal corporate assets, the company and the Ninth Academy of Aerospace jointly increased capital for the subsidiary Long March Rocket. In the first half of 18, the subsidiary Aerospace Feihong was established.With the advancement of the transformation of the aerospace science and technology group military industrial research institute to facilitate the listing of the institute’s assets, the affiliated assets of the Ninth Academy are expected to continue to be injected into the listed companies, which will further strengthen the company’s scientific research strength and increase company performance. Profit forecast and investment advice: We predict that the company will achieve 151 revenue in 2019-2021.45/169.65/191.30 ppm, an increase of 11 years.94% / 12.01% / 12.76%; realized net profit attributable to mother 5.27/6.07/7.09 million yuan, an increase of 15 in ten years.41% / 15.23% / 16.76%, corresponding to 19-21 years P / E were 31/27/23 times.With the rapid development of the national aerospace industry, the advancement of military-civilian integration and commercial aerospace, the company’s revenue continues to grow steadily, and it will also benefit from the group’s asset securitization and institutional reform.Maintain “Buy” rating. Risk reminder: the competition in the weapon and equipment supporting market is intensifying; the risk of overcapacity in the wire and cable industry; the group’s asset securitization is less than expected; the scientific research institute is restructured;